Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease

BACKGROUND: Diabetes is the commonest cause of chronic kidney disease (CKD). Both conditions commonly co‐exist. Glucometabolic changes and concurrent dialysis in diabetes and CKD make glucose‐lowering challenging, increasing the risk of hypoglycaemia. Glucose‐lowering agents have been mainly studied...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Lo, Clement, Toyama, Tadashi, Wang, Ying, Lin, Jin, Hirakawa, Yoichiro, Jun, Min, Cass, Alan, Hawley, Carmel M, Pilmore, Helen, Badve, Sunil V, Perkovic, Vlado, Zoungas, Sophia
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2018
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513625/
https://ncbi.nlm.nih.gov/pubmed/30246878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011798.pub2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky